Evidence map›Paper›PMID 41356728›Full record

ArticleAsia-Pacific journal of oncology nursing2025

Dyadic coping and fear of cancer progression among patients with hepatocellular carcinoma and their spouses in China: An actor-partner interdependence model.

Rukang Hu, Huijuan Lu, Jingxian Yu, Zheng Zhu

Abstract read
In one paragraph

Article in Asia-Pacific journal of oncology nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rukang HuSchool of Nursing, Fudan University, Shanghai, China.
Huijuan LuSchool of Nursing, Fudan University, Shanghai, China.
Jingxian YuZhongshan Hospital, Fudan University, Shanghai, China.
Zheng ZhuSchool of Nursing, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study examined the relationship between dyadic coping and fear of cancer progression (FoP) in patients with hepatocellular carcinoma (HCC) and their spouses to provide insights into their interrelations and inform future couple-based practice. Methods: This cross-sectional study included 305 HCC patients and their spousal dyads. FoP and dyadic coping were measured using the 12-item FoP Questionnaire-Short Form (FoP-Q-SF) and Dyadic Coping Inventory, respectively, and administered to both patients and spouses. The actor-partner interdependence model (APIM) was applied via structural equation modeling to evaluate the relationships between different dyadic coping and FoP dimensions. Results: Of the participants, 54.1% of patients and 67.2% of spouses experienced high FoP (FoP-Q-SF ​≥ ​34). Compared with patients, spouses experienced more severe FoPs. Based on the APIM, patients' and spouses' dyadic coping strategies exhibited significant actor and partner effects on FoP. Particularly, positive dimensions of dyadic coping were negatively associated with FoP, whereas negative dimensions of dyadic coping were positively associated with FoP. Patients seemed to benefit more from positive dyadic coping than from their spouses regarding FoP reduction. Conclusions: Spouses had a higher FoP than patients with HCC. While dyadic coping lowered FoP in patients, it had a limited influence on spouses. Since negative coping emerged as a shared risk factor, clinical interventions have to focus on lowering maladaptive coping among partners.

Indexed as

Actor–partner interdependence modelCoping strategiesCoupleDyadic copingFear of cancer progressionHepatocellular carcinoma

Identifiers

PMID41356728
PMCPMC12677183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.